[{"Assets_0_Q3_USD":"10915900000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.24","CommonStockSharesIssued_0_Q3_shares":"133700000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.44","EarningsPerShareBasic_3_Q3_USD":"-0.59","EarningsPerShareDiluted_1_Q3_USD":"-0.44","EarningsPerShareDiluted_3_Q3_USD":"-0.59","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"261700000.0","NetIncomeLoss_1_Q3_USD":"-58900000.0","NetIncomeLoss_3_Q3_USD":"-78500000.0","OfficialName":"Perrigo Company plc Ordinary Shares","PaymentsOfDividends_3_Q3_USD":"97800000.0","RevenuesConverted_1_Q3_USD":"1042700000.0","RevenuesConverted_3_Q3_USD":"3033800000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"5182400000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"133800000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"133500000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"133800000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"133500000.0","filed":"20211112","footnote":null,"form":"10-Q","fp":"Q3","fy":"2021.0","name":"PERRIGO CO PLC","period":"20210930","qtrs":"0","uom":"USD"}]